Back

Advanced mapping and ablation technologies to target pulmonary veins gaps and residual antral potentials during repeat paroxysmal AF ablation: acute and long-term follow-up

31 August 2024 (14:00 - 14:50)
Organised by: Logo
Congress Presentation Part of: Ablation technologies and predictors for atrial fibrillation recurrence Rhythm Control, Catheter Ablation ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Luca Segreti

University Hospital of Pisa, Pisa (Italy)

7 More presentations in this session

Presentation thumbnail
The correlation between left atrium voltage mapping and 3D late gadolinium enhancement cardiac magnetic resonance imaging findings in naive AF ablation candidate
Doctor A. Wolak (Jerusalem, IL)
Abstract Slides Video
Presentation thumbnail
Clonal haematopoiesis of indeterminate potential predicts recurrence of atrial arrhythmias after surgical ablation for atrial fibrillation
Doctor Z. Zeng (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Duration of sinus rhythm after direct current cardioversion does not predict recurrence of atrial fibrillation after subsequent catheter ablation: a multicentre study
Doctor P. Tang (Oxford, GB)
Abstract Slides Video
Presentation thumbnail
Organization of atrial flutter during pulse field ablation for atrial fibrillation
Doctor V. La Fazia (Austin, US)
Abstract Slides Video
Presentation thumbnail
Impact of altered pulmonary vein anatomy on long-term outcomes after cryoablation of paroxysmal atrial fibrillation
Doctor A. Baimbetov (Almaty, KZ)
Abstract Slides Video

Access the full session

Session thumbnail
Ablation technologies and predictors for atrial fibrillation recurrence

The Event

Event poster

ESC Congress 2024

31 August 2024 14:00 CET
You may be interested in
thumbnail
Congress Session
Atrial fibrillation catheter ablation (1)
thumbnail
Congress Session
Atrial fibrillation: ablation 2
thumbnail
Congress Presentation
Ppulsed field ablation and ultra-high-density mapping for PVI: use of machine learning and data augmentation to guide procedure and identify recurrent tachycardia mechanisms at one-year follow-up

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources